|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-02
|
$347,563
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$5,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$104,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
5R01CA044722-25
|
$222,013
|
$111,007
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
5R01CA135332-05
|
$316,438
|
$158,219
|
MUTHUSAMY, NATARAJAN
|
OHIO STATE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$749
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$3,956
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$1,250
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$683
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$2,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$15,350
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-03S1
|
$250,000
|
$12,500
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-03S2
|
$125,000
|
$6,250
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
5P30CA177558-03
|
$1,505,000
|
$75,250
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S5
|
$1,213,480
|
$60,674
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S6
|
$48,256
|
$2,413
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Translational Research in Cancer
|
5P30CA056036-16
|
$2,807,751
|
$56,155
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
5R37CA072614-19
|
$304,773
|
$304,773
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$754,029
|
$75,403
|
Larson, Daniel
|
CCR (NCI)
|
|
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
|
5R01CA151319-05
|
$34,752
|
$34,752
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
5R01CA166280-03
|
$318,513
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
1P30CA196521-01
|
$1,695,000
|
$457,650
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
5R01CA160433-04
|
$336,150
|
$336,150
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
|
5R01CA174205-03
|
$320,588
|
$320,588
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
|
5K99CA181488-02
|
$176,720
|
$176,720
|
LOSMAN, JULIE
|
DANA-FARBER CANCER INST
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-21S1
|
$79,482
|
$4,769
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-21
|
$4,814,560
|
$288,874
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
5R01CA167169-03
|
$321,625
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Targeting BCL6 in tyrosine kinase-driven leukemia
|
5R01CA169458-03
|
$328,714
|
$164,357
|
MUSCHEN, MARKUS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-05
|
$317,475
|
$317,475
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$371,630
|
$92,907
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Studies of BCR-ABL leukemogenesis in mice
|
5R01CA090576-15
|
$274,559
|
$274,559
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes
|
1R21CA195689-01
|
$208,800
|
$208,800
|
NAORA, HONAMI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-02
|
$671,104
|
$671,104
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Statistical analysis methods for validating risk prediction models
|
5R21CA185704-02
|
$188,138
|
$94,069
|
UNO, HAJIME
|
DANA-FARBER CANCER INST
|
|
Stanford University Cancer Center
|
3P30CA124435-08S3
|
$2,249,153
|
$22,492
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
|
5P50CA100632-13
|
$2,183,683
|
$87,347
|
KANTARJIAN, HAGOP
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-12
|
$1,308,390
|
$183,175
|
HANNUN, YUSUF
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-29S1
|
$25,059
|
$2,005
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-29S2
|
$50,000
|
$4,000
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-29S3
|
$92,737
|
$7,419
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-29S4
|
$116,250
|
$9,300
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-29S5
|
$82,610
|
$6,609
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-29
|
$3,795,641
|
$303,651
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
1U54CA193419-01
|
$1,989,491
|
$915,166
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
|
5R01CA175215-03
|
$583,874
|
$583,874
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Single cell cytokine analysis of circulating malignant hematopoietic cells
|
1R33CA196411-01
|
$421,227
|
$421,227
|
FAN, RONG
|
YALE UNIVERSITY
|
|
Signal Transduction of Type 1 Interferons in Malignant Cells
|
5R01CA077816-17
|
$298,913
|
$298,913
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $32,556,862
|